OR WAIT null SECS
January 25, 2019
Full commercial launch of the drug is underway in the United States, with Europe to follow.
January 14, 2019
The company is set to expand biologics and fill/finish capacity at its biologics manufacturing sites in Madison, WI, and Bloomington, IN.
January 10, 2019
Fujifilm increases capacity of its Bio-CDMO business with an expansion of production in North Carolina.
January 03, 2019
The Massachusetts site, formerly associated with an affiliate of Shire, is Rentschler Biopharma’s first facility in the US.
January 02, 2019
Requirements for virus filtration must be considered in developing continuous downstream processes.
November 30, 2018
Contract development and manufacturing organization (CDMO), Yposkesi, has entered into an agreement in principle with Axovant Sciences.
November 26, 2018
ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.
November 14, 2018
Experts believe that the contract development and manufacturing organization market will reach $17.38 billion by 2022, with disruptive business models using Industrial Internet of Things (IIot) and single-use technologies proving more profitable and efficient in the long term.
November 06, 2018
The expansion adds new capabilities and enhances existing service offerings for both oral and parenteral dosage forms.
The company has rolled out the first batch of TRACON Pharmaceutical’s lead product candidate from its Singapore-based single-use bioreactor.